These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31469221)

  • 1. Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3.
    Ceballos J; Schwalfenberg M; Karageorgis G; Reckzeh ES; Sievers S; Ostermann C; Pahl A; Sellstedt M; Nowacki J; Carnero Corrales MA; Wilke J; Laraia L; Tschapalda K; Metz M; Sehr DA; Brand S; Winklhofer K; Janning P; Ziegler S; Waldmann H
    Angew Chem Int Ed Engl; 2019 Nov; 58(47):17016-17025. PubMed ID: 31469221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3.
    Karageorgis G; Reckzeh ES; Ceballos J; Schwalfenberg M; Sievers S; Ostermann C; Pahl A; Ziegler S; Waldmann H
    Nat Chem; 2018 Nov; 10(11):1103-1111. PubMed ID: 30202104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
    Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
    Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Molecule Inhibition of Glucose Transporters GLUT-1-4.
    Reckzeh ES; Waldmann H
    Chembiochem; 2020 Jan; 21(1-2):45-52. PubMed ID: 31553512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Indofulvin Pseudo-Natural Products Yields a New Autophagy Inhibitor Chemotype.
    Burhop A; Bag S; Grigalunas M; Woitalla S; Bodenbinder P; Brieger L; Strohmann C; Pahl A; Sievers S; Waldmann H
    Adv Sci (Weinh); 2021 Oct; 8(19):e2102042. PubMed ID: 34346568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprecedented Combination of Polyketide Natural Product Fragments Identifies the New Hedgehog Signaling Pathway Inhibitor Grismonone.
    Grigalunas M; Patil S; Krzyzanowski A; Pahl A; Flegel J; Schölermann B; Xie J; Sievers S; Ziegler S; Waldmann H
    Chemistry; 2022 Dec; 28(67):e202202164. PubMed ID: 36083197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells.
    Rivenzon-Segal D; Rushkin E; Polak-Charcon S; Degani H
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E508-19. PubMed ID: 10950817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Phenotypic Profiling of Pyrano-Furo-Pyridone Pseudo Natural Products.
    Christoforow A; Wilke J; Binici A; Pahl A; Ostermann C; Sievers S; Waldmann H
    Angew Chem Int Ed Engl; 2019 Oct; 58(41):14715-14723. PubMed ID: 31339620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype.
    Schneidewind T; Kapoor S; Garivet G; Karageorgis G; Narayan R; Vendrell-Navarro G; Antonchick AP; Ziegler S; Waldmann H
    Cell Chem Biol; 2019 Apr; 26(4):512-523.e5. PubMed ID: 30686759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLUT1 biological function and inhibition: research advances.
    Cao S; Chen Y; Ren Y; Feng Y; Long S
    Future Med Chem; 2021 Jul; 13(14):1227-1243. PubMed ID: 34018847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping Reveals Targets of a Pseudo-Natural-Product Autophagy Inhibitor.
    Foley DJ; Zinken S; Corkery D; Laraia L; Pahl A; Wu YW; Waldmann H
    Angew Chem Int Ed Engl; 2020 Jul; 59(30):12470-12476. PubMed ID: 32108411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.
    Liu Y; Cao Y; Zhang W; Bergmeier S; Qian Y; Akbar H; Colvin R; Ding J; Tong L; Wu S; Hines J; Chen X
    Mol Cancer Ther; 2012 Aug; 11(8):1672-82. PubMed ID: 22689530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
    Airley RE; Mobasheri A
    Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of beta-adrenoceptors in memory consolidation: beta3-adrenoceptors act on glucose uptake and beta2-adrenoceptors on glycogenolysis.
    Gibbs ME; Hutchinson DS; Summers RJ
    Neuropsychopharmacology; 2008 Sep; 33(10):2384-97. PubMed ID: 18046311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT3 inhibitor discovery through in silico ligand screening and in vivo validation in eukaryotic expression systems.
    Iancu CV; Bocci G; Ishtikhar M; Khamrai M; Oreb M; Oprea TI; Choe JY
    Sci Rep; 2022 Jan; 12(1):1429. PubMed ID: 35082341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the association with diabetes say more about schizophrenia and its treatment?--the GLUT hypothesis.
    De Silva PN
    Med Hypotheses; 2011 Oct; 77(4):529-31. PubMed ID: 21719205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pseudo-Natural Product Rhonin Targets RHOGDI.
    Akbarzadeh M; Flegel J; Patil S; Shang E; Narayan R; Buchholzer M; Kazemein Jasemi NS; Grigalunas M; Krzyzanowski A; Abegg D; Shuster A; Potowski M; Karatas H; Karageorgis G; Mosaddeghzadeh N; Zischinsky ML; Merten C; Golz C; Brieger L; Strohmann C; Antonchick AP; Janning P; Adibekian A; Goody RS; Ahmadian MR; Ziegler S; Waldmann H
    Angew Chem Int Ed Engl; 2022 Apr; 61(18):e202115193. PubMed ID: 35170181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of glucose transporters (GLUT-1 and GLUT-3) in human retinal endothelial cells.
    Knott RM; Robertson M; Muckersie E; Forrester JV
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):313-7. PubMed ID: 8761487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural product fragment combination to performance-diverse pseudo-natural products.
    Grigalunas M; Burhop A; Zinken S; Pahl A; Gally JM; Wild N; Mantel Y; Sievers S; Foley DJ; Scheel R; Strohmann C; Antonchick AP; Waldmann H
    Nat Commun; 2021 Mar; 12(1):1883. PubMed ID: 33767198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
    Brown RS; Wahl RL
    Cancer; 1993 Nov; 72(10):2979-85. PubMed ID: 8221565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.